An 83-year-old patient's three-decade psoriasis journey, shaped by a comorbid MGUS diagnosis and a hospitalization that ...

Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing ...

Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting ...

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.

Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.

From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology ...

Lutikizumab (ABT-981) met its primary end point and all 8 ranked secondary end points in the phase 3 INTREPID trial ...

A melanoma expert discusses gaps in dermoscopy education, cognitive bias during skin examinations, and strategies to improve ...

This episode, "Efficacy and Safety Data for Emerging Oral HS Agents," has Chao presenting the latest trial results for ...

Menopause can bring dryness, sensitivity, acne, and loss of firmness, requiring dermatologists to adapt skin care to patients ...

At Horizons in Advanced Practice, Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed oral and targeted psoriasis therapies and ...

Mark Lebwohl, MD, discusses atopic march data and systemic treatment options for pediatric atopic dermatitis. Mark Lebwohl, ...